Showing results (1771-1780 of 2,266) with videos related to
Sort By:
Pageof 227
International Journal of Antimicrobial Agents|March 28, 2009
sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureusReena Lamichhane-Khadka, Stephanie A Cantore, James T Riordan, et al.Journal of Integrative Bioinformatics|August 5, 2020
Systems Biology Markup Language (SBML) Level 3 Package: Distributions, Version 1, Release 1Lucian P Smith, Stuart L Moodie, Frank T Bergmann, et al.The Lancet. Microbe|June 1, 2022
Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort studyLinda Boloko, Charlotte Schutz, Nomfundo Sibiya, et al.Archives of Pathology & Laboratory Medicine|October 21, 2016
Evaluation of the Vulvar Cancer Histology Code Reported by Central Cancer Registries: Importance in EpidemiologyDavid A Siegel, Reda Wilson, Edward J Wilkinson, et al.ACS Infectious Diseases|October 31, 2023
Bromodomain Factor 5 as a Target for Antileishmanial Drug DiscoveryCatherine N Russell, Jennifer L Carter, Juliet M Borgia, et al.The British Journal of Surgery|May 14, 2015
Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinibM J Wilkinson, J E F Fitzgerald, D C Strauss, et al.The Journal of Clinical Endocrinology and Metabolism|April 30, 2010
Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin DRene F Chun, Anna L Lauridsen, Lizabeth Suon, et al.Diabetes Research and Clinical Practice|November 25, 2022
Individual frailty phenotype components and mortality in adults with type 2 diabetes: A UK Biobank studyMonika Mickute, Francesco Zaccardi, Cameron Razieh, et al.British Journal of Clinical Pharmacology|January 9, 2020
Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosisCharlotte Schutz, Maxwell Chirehwa, David Barr, et al.Antimicrobial Agents and Chemotherapy|November 15, 2023
A preclinical model of TB meningitis to determine drug penetration and activity at the sites of diseaseFaye Lanni, Rosleine Antilus Sainte, Mark Hansen, et al.Pageof 227